Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

Update Il y a 4 ans
Reference: NCT01056263

Woman and Man

Extract

The primary objective of this observational study is to retrospectively collect current survival data for patients originally included in axitinib A4061012 [NCT00076011] study to estimate the 5-year survival rate in subjects with metastatic renal cancer cell treated with axitinib.


Inclusion criteria

  • Carcinoma, Renal Cell

Links